Safety assessment of McB-E60 (extract of a Momordica sp.): Subchronic toxicity study in rats

  title={Safety assessment of McB-E60 (extract of a Momordica sp.): Subchronic toxicity study in rats},
  author={Narendra S Deshmukh},
  journal={Toxicology Reports},
  pages={481 - 489}
Highlights • Subchronic toxicity of McB-E60 (extract of a Momordica sp.) was investigated in rats.• McB-E60 (extract of a Momordica sp.) administration to rats at doses up to 1000 mg/kg bw/day for 90 days did not reveal any effects.• The No Observed-Effect Level (NOEL) for McB-E60 (extract of a Momordica sp.) was determined as greater than 1000 mg/kg bw/day, the highest dose tested. 
3 Citations
Bitter gourd (Momordica charantia) possess developmental toxicity as revealed by screening the seeds and fruit extracts in zebrafish embryos
The teratogenicity of seeds extract and cardiac toxicity by the fruit extract of M. charantia is found to be much safe and exposing the zebrafish embryos even to 200 μg/ml did not result any lethality, but the fruit Extract induced severe cardiac hypertrophy in treated embryos. Expand
A simple, cost-effective, and rapid separation process for the isolation of anticoagulant active fraction from the fruit extract of Momordica charantia: Characterization of bioactive components and anticoagulant mechanism of active fraction in a mouse model.
The active anticoagulant fraction demonstrated biding to fibrinogen but not to thrombin or Factor Xa, inhibited the collagen/ADP-induced mammalian platelet aggregation, showed in vitro thrombolytic activity, non-cytotoxic to mammalian cells, and showed in vivo plasma defibr inogenation and anticoAGulant activities, and inhibited k-carrageen-induced thrombus formation in the tails of mice. Expand
An inventory of medicinal plants used for treatment of cancer in Kwara and Lagos state, Nigeria
It is revealed that medicinal plants previously shown to have cytotoxicity in vitro are currently used for cancers in traditional medicine practice and could serve as sources for novel cytotoxic agents against cancers. Expand


Demonstration of the hypoglycemic action of Momordica charantia in a validated animal model of diabetes.
Data suggest that the mechanism of action of M. charantia could be partly attributed to increased glucose utilization in the liver rather than an insulin secretion effect, as well as improving the oral glucose tolerance in streptozotocin diabetes rats. Expand
Anti-diabetic properties and phytochemistry of Momordica charantia L. (Cucurbitaceae).
  • A. Raman, C. Lau
  • Biology, Medicine
  • Phytomedicine : international journal of phytotherapy and phytopharmacology
  • 1996
Animal and in vitro data support both insulin secretagogue and insulinomimetic activity of the fruit, however, enhanced insulin levels in vivo in response to its administration have not been observed. Expand
No effect of acute, single dose oral administration of Momordica charantia Linn., on glycemia, energy expenditure and appetite: a pilot study in non-diabetic overweight men.
The results suggest that from an acute standpoint, a freeze dried MC extraction in its present dose form does not affect plasma glucose/insulin levels, energy expenditure, substrate mixture and appetite scores following an oral glucose load in non-diabetic overweight men. Expand
Bitter gourd (Momordica Charantia): A dietary approach to hyperglycemia.
Bitter gourd has the potential to become a component of the diet or a dietary supplement for diabetic and prediabetic patients and well-designed interdisciplinary research by nutritionists, medical doctors, and agronomists is needed before a dietary recommendation can be given and a product brought to the market. Expand
Pharmacological actions and potential uses of Momordica charantia: a review.
Popularity of Momordica charantia in various systems of traditional medicine for several ailments and its efficacy in various cancers, as antibacterial as well as antiviral agent (including HIV infection), as anthelmintic and abortifacient are authenticated. Expand
Potential for Improved Glycemic Control with Dietary Momordica charantia in Patients with Insulin Resistance and Pre-Diabetes
The benefits and limitations of bitter melon supplementation in the context of epidemic levels of insulin resistance and pre-diabetes throughout the world are discussed. Expand
The role of complementary and alternative medicine in diabetes
Several CAM practices and herbal remedies are promising for diabetes treatment, but further rigorous study is needed in order to establish safety, efficacy, and mechanism of action. Expand
Mechanisms of vascular complications in prediabetes.
This article reviews some of the proposed mechanisms for the vascular complications of the prediabetic state and suggests strategies to address these mechanisms. Expand
Prediabetes: the effects on arterial thickness and stiffness in obese youth.
Youth with predi diabetes have worse cardiometabolic risk factors and evidence of increased arterial thickness and stiffness and interventions to prevent prediabetes are crucial to reduce the development of early arterial disease. Expand
Animal behavioral methods in neurotoxicity assessment: SGOMSEC joint report.
ImagesFigure 2.